I rarely respond to board messages but your message prompted a response. I too am an old market player and in fact I still have my original purchase confirmation which was 100 shares of Hazel Bishop (an old cosmetic company) which I bought on Sept.12, 1955 at 6 3/8 and sold 7 days later on Sept.19 at the same 6 3/8.
Your comments concerning Geron make perfect sense. I too firmly believe that there isn't a single major pharmaceutical company that is not salivating to get into the stem cell area and we all know that the strongest name in this business is Geron's. It is also my firm belief that many of these formidable companies have indicated this interest directly to Geron and that Geron has decided there is no reason in the world why it should not remain independent and reap the enormous benefits that lie ahead. If Geron was short of cash necessary to conduct their business then of course they would partner at this time but their cash position is sufficient for the near term. By the time they will need additional funds the market will have given it the appropriate market value enabling it to raise funds very easily from willing sources.
Any investor in Geron should understand that this company is not a one horse pony. It is riding on many tracks, any one of which, if successful, would make the investor very wealthy. Geron is not in the business of building a better mouse trap, it is in the business of saving and improving life for every individual in the world. This is not theory or dreams but a reality. It is just a matter of time when this breakthrough occurs and I want to be part of it when it happens.